Crown Equity Holdings Inc. (CRWE) CRWE AD-Services, a division of CRWE is a full service multimedia advertising company specializing in internet marketing. Their goal is to provide you with a customized advertising blue print using their expansive resources. CRWE Ad Services (www.crwe-adservices.com ) provides modern and unique advertising campaigns. They are dedicated to offering the most cost effective advertising solutions. CRWE offers advertising branding and marketing services as a worldwide online multi-media publisher with its digital network of websites and focuses on the distribution of information for the purpose of bringing together a targeted audience and the advertisers that want to reach them. CRWE advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness. For more information about Crown Equity Holdings Inc. visit www.crownequityholdings.com. O'Reilly Automotive, Inc. (Nasdaq:ORLY) plans to offer 300 million aggregate principal amount of its Senior Notes due 2022. The Company intends to use the net proceeds of the offering for general corporate purposes, including ordinary course working capital increases, repurchases of shares of common stock, repayment of debt and other business opportunities, and to pay related fees and expenses. New York Mortgage Trust, Inc. (Nasdaq:NYMT) reported that it priced an underwritten registered public offering of 10,000,000 shares of common stock at a public offering price of 6.73 per share. NYMT also granted the underwriters an option to purchase up to an additional 1,500,000 shares of common stock. The offering is subject to customary closing conditions and is expected to close on August 21, 2012. Deutsche Bank Securities Inc. is serving as the sole bookrunning manager for the offering. Ladenburg Thalmann Co. Inc. is serving as co-manager. Apricus Biosciences, Inc. (Nasdaq:APRI) reported a podium presentation
titled, "Updated analyses of a randomized, double-blind, Phase 3 study of Femprox(r), an alprostadil cream with a novel transdermal delivery technology (NexACT(r)) for the treatment of female sexual-arousal disorder (FSAD)," will take place on Monday, August 27, 2012, at 4:30 p.m. CT, as part of the 2012 World Meeting on Sexual Medicine, which is being held August 26-30, 2012 in Chicago. For FREE Daily Stock Alerts Updates Sign-up At: http://pennytobuck.com/signup THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyToBuck.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer (http://pennytobuck.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyToBuck.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE) advertises for a particular client, Crown Equity Holdings Inc. (CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE), if paid in stock, can and may sell those securities during the advertising period.